Category: Insurance

RPA M&A: SS&C and Blue Prism

RPA M&A: SS&C and Blue Prism

SS&C Technologies' (tkr: SSNC) preliminary approach about a potential offer for U.K.-based RPA ("Robotic Process Automation"), firm Blue Prism is detailed below. Read Blue Prism's deal press release HERE.SS&C's proposal values Blue Prism at approximately $1.6 billion. Blue Prism generated recurring revenue of approximately 154 million GBP in FY'20. Read Blue Prism's 1H 2021 investor … Continue reading RPA M&A: SS&C and Blue Prism

The Fed’s Digital Dollar Will Remake The Capital Markets

The Fed’s Digital Dollar Will Remake The Capital Markets

From instant trade settlement, to real-time AML transparency and reporting, the Fed's CBDC / "Digital Dollar" will drive efficiency, enhance transparency and reduce privacy. "We are the Federal Reserve and we are here to help" (translation: run for cover). The Federal Reserve will have rolled out its CBDC - the Digital Dollar - by 2025 … Continue reading The Fed’s Digital Dollar Will Remake The Capital Markets

Insurance M&A Will Drive InsurTech M&A

Insurance M&A Will Drive InsurTech M&A

We expect that Claims Processing technology providers will merge with one another (P&C with Health & Life) as well as with Policy Administration technology providers to better serve insurance company customers as insurance M&A continues its rapid pace (See the Chubb / Cigna A&H deal HERE). One hypothetical M&A example would be Solera (P&C) merging … Continue reading Insurance M&A Will Drive InsurTech M&A

Leveraging Alternative Assets To Increase Yield

Leveraging Alternative Assets To Increase Yield

Insurance company CIOs continue to use Alternative Assets to increase yield in this ultra-low interest rate environment. KKR Asset Management's Insurance CIO survey found similar results (chart below) to our recent TEK2day Spotlight report on the insurance industry which may be accessed HERE. We expect that the heavy use of Alternative Assets in the pursuit … Continue reading Leveraging Alternative Assets To Increase Yield

TEK2day Podcast Ep. 441: Insurers & Alternative Asset Investing with SS&C Technologies

TEK2day Podcast Ep. 441: Insurers & Alternative Asset Investing with SS&C Technologies

We published our TEK2day Spotlight report - The Evolving Insurance Industry - a few weeks ago. We hosted a follow-up podcast episode with two of the SS&C Technologies (ticker: SSNC), executives that were involved with that effort. You may view the video podcast at the YouTube link below. If any difficulties, simply visit CEORater's YouTube … Continue reading TEK2day Podcast Ep. 441: Insurers & Alternative Asset Investing with SS&C Technologies

Google To Dissolve Google Health

Google To Dissolve Google Health

Google Health's CEO is to become Cerner's CEO. Google will allocate its Health projects to different parts of the organization. This wreaks of government interference. Cerner and Epic are two prime examples of large, established Healthcare IT players that should have been acquired by some combination of Amazon, Apple, Google or Microsoft by now. The … Continue reading Google To Dissolve Google Health

SS&C Technologies Is Worth A Look

SS&C Technologies Is Worth A Look

Many investors were waiting for SS&C Technologies (ticker: SSNC) to return to organic revenue growth. The company recently checked that box in Q1 2021 and organic growth accelerated in Q2 (read more HERE). SSNC remains a relative value versus the peer group at 23x Enterprise Value to Trailing Operating Cash Flow. Further, SS&C is generating … Continue reading SS&C Technologies Is Worth A Look

TEK2day Spotlight: The Evolving Insurance Industry

TEK2day Spotlight: The Evolving Insurance Industry

TEK2day Spotlights are sponsored reports that focus on a particular industry and/or technologies. M&A Activity & Low Interest Rates, Product & Process Innovation and Digital Transformation & Advanced Automation are some of the catalysts driving change within the global insurance industry. Click HERE to access the full report. Reach us at info@tek2day.com with any questions.